Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.45 Million shares of MRNA, which is worth approximately $37.1 Million. The most recent transaction as insider was on Nov 13, 2020, when has been sold 10,000 shares (Common Stock) at a price of $0.99 per share, resulting in proceeds of $9,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.45M

0.1% 3M change

0.34% 12M change

Total Value Held $37.1 Million

Stephen Hoge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 13 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.57%	1,759,597 Common Stock
Nov 12 2020	SELL Open market or private sale	$431,400 $86.28 p/Share	5,000 Reduced 0.28%	1,749,597 Common Stock
Nov 03 2020	SELL Open market or private sale	$667,500 $66.75 p/Share	10,000 Reduced 0.57%	1,754,597 Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.56%	1,764,597 Common Stock
Nov 02 2020	SELL Open market or private sale	$680,200 $68.02 p/Share	10,000 Reduced 0.57%	1,754,597 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.56%	1,764,597 Common Stock
Oct 26 2020	SELL Open market or private sale	$352,050 $70.41 p/Share	5,000 Reduced 0.28%	1,754,597 Common Stock
Oct 23 2020	SELL Open market or private sale	$1,056,150 $70.41 p/Share	15,000 Reduced 0.78%	1,911,530 Common Stock
Oct 23 2020	SELL Bona fide gift	-	151,933 Reduced 7.95%	1,759,597 Common Stock
Oct 23 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.52%	1,926,530 Common Stock
Oct 13 2020	SELL Open market or private sale	$1,175,550 $78.37 p/Share	15,000 Reduced 0.78%	1,916,530 Common Stock
Oct 13 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.52%	1,931,530 Common Stock
Oct 12 2020	SELL Open market or private sale	$371,800 $74.36 p/Share	5,000 Reduced 0.26%	1,921,530 Common Stock
Oct 05 2020	SELL Open market or private sale	$695,000 $69.5 p/Share	10,000 Reduced 0.52%	1,926,530 Common Stock
Oct 05 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.51%	1,936,530 Common Stock
Oct 02 2020	SELL Open market or private sale	$678,600 $67.86 p/Share	10,000 Reduced 0.52%	1,926,530 Common Stock
Oct 02 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.51%	1,936,530 Common Stock
Sep 24 2020	SELL Open market or private sale	$326,650 $65.33 p/Share	5,000 Reduced 0.26%	1,926,530 Common Stock
Sep 23 2020	SELL Open market or private sale	$1,009,050 $67.27 p/Share	15,000 Reduced 0.77%	1,931,530 Common Stock
Sep 23 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.51%	1,946,530 Common Stock
Sep 14 2020	SELL Open market or private sale	$1,242,600 $62.13 p/Share	20,000 Reduced 1.02%	1,936,530 Common Stock
Sep 14 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.51%	1,956,530 Common Stock
Sep 03 2020	SELL Open market or private sale	$656,500 $65.65 p/Share	10,000 Reduced 0.51%	1,946,530 Common Stock
Sep 03 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.51%	1,956,530 Common Stock
Sep 02 2020	SELL Open market or private sale	$628,900 $62.89 p/Share	10,000 Reduced 0.51%	1,946,530 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director

Stephen Hoge

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account